78 related articles for article (PubMed ID: 21277347)
21. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
[TBL] [Abstract][Full Text] [Related]
22. Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia.
Kabarowski JH; Witte ON
Stem Cells; 2000; 18(6):399-408. PubMed ID: 11072027
[TBL] [Abstract][Full Text] [Related]
23. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
[TBL] [Abstract][Full Text] [Related]
24. Therapy-related acute leukemia.
Karp JE; Sarkodee-Adoo CB
Clin Lab Med; 2000 Mar; 20(1):71-81, ix. PubMed ID: 10702897
[TBL] [Abstract][Full Text] [Related]
25. [Leukemias and malignant lymphomas in children].
Schmiegelow K
Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
[No Abstract] [Full Text] [Related]
26. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
[TBL] [Abstract][Full Text] [Related]
27. The fundamental prevalence of chronic myeloid leukemia-generating clonogenic cells in the light of the neutrality theory of evolution.
Jankovic GM; Pavlovic M; Vukomanovic DJ; Colovic MD; Lazarevic V
Blood Cells Mol Dis; 2001; 27(5):913-7. PubMed ID: 11783955
[TBL] [Abstract][Full Text] [Related]
28. Recombinant interferon beta in chronic myelogenous leukemia.
Aulitzky WE; Després D; Rudolf G; Aman J; Peschel C; Huber C
Semin Hematol; 1993 Jul; 30(3 Suppl 3):14-6. PubMed ID: 7694372
[No Abstract] [Full Text] [Related]
29. Investigation of bcr-abl transcription by Ph-positive chronic myeloid leukemia progenitors.
Keating A
Stem Cells; 1993 Oct; 11 Suppl 3():31-3. PubMed ID: 8298475
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy to treat leukemia possibly ineffective for advanced disease.
Sinha G
J Natl Cancer Inst; 2013 Aug; 105(15):1068-9. PubMed ID: 23884051
[No Abstract] [Full Text] [Related]
31. [Properties of leukemic stem cells and treatment strategy for the cure of chronic myelogenous leukemia].
Minami Y
Rinsho Ketsueki; 2013 Jun; 54(6):552-8. PubMed ID: 23823094
[No Abstract] [Full Text] [Related]
32. Genetic separation of chronic myeloid leukemia stem cells from normal hematopoietic stem cells at single-cell resolution.
Chen Y; Möbius S; Riege K; Hoffmann S; Hochhaus A; Ernst T; Rudolph KL
Leukemia; 2023 Jul; 37(7):1561-1566. PubMed ID: 37237078
[No Abstract] [Full Text] [Related]
33. Methylenetetrahydrofolate reductase gene polymorphisms contribute to acute myeloid leukemia and chronic myeloid leukemia susceptibilities: appraisal of a recent meta-analysis.
Wang F; Sun G
Cancer Epidemiol; 2014 Dec; 38(6):773-4. PubMed ID: 25455654
[No Abstract] [Full Text] [Related]
34. [Overview].
Gotoh A
Rinsho Ketsueki; 2016 Feb; 57(2):117. PubMed ID: 26935628
[No Abstract] [Full Text] [Related]
35. Personalized medicine for acute myelogenous leukemia--at the entrance gate.
Swords RT; Dezube BJ; Medeiros BC
Am J Hematol; 2011 Aug; 86(8):631-2. PubMed ID: 21761430
[No Abstract] [Full Text] [Related]
36. Targeting cytokine-induced leukemic stem cell persistence in chronic myeloid leukemia by IKK2-inhibition.
Bütow M; Testaquadra FJ; Baumeister J; Maié T; Chatain N; Jaquet T; Tillmann S; Crysandt M; Costa IG; Brümmendorf TH; Schemionek M
Haematologica; 2023 Apr; 108(4):1179-1185. PubMed ID: 36453102
[No Abstract] [Full Text] [Related]
37. Response to “Methylenetetrahydrofolate reductase gene polymorphisms contribute to acute myeloid leukemia and chronic myeloid leukemia susceptibilities: appraisal of a recent meta-analysis” by Fang Wang and Prof. Guoping Sun.
He H; He G; Wang T; Cai J; Wang Y; Zheng X; Dong Y; Lu J
Cancer Epidemiol; 2014 Dec; 38(6):775-6. PubMed ID: 25454263
[No Abstract] [Full Text] [Related]
38. Guest editorial: chronic myeloid leukemia.
Minami Y
Int J Hematol; 2018 Oct; 108(4):353-354. PubMed ID: 30155590
[No Abstract] [Full Text] [Related]
39. International conference on chronic myelocytic leukemia: biology and treatment organised by the Scientific Committee of The Israel Society of Hematology, Jerusalem, Israël, 28-31 January 1996.
Janković GM; Colović MD
Leukemia; 1996 Oct; 10(10):1667-70. PubMed ID: 8847905
[No Abstract] [Full Text] [Related]
40. Canadian Journal of Cardiology in 2014: from percutaneous intervention to regenerative medicine.
Nattel S
Can J Cardiol; 2014 Jan; 30(1):1-2. PubMed ID: 24365187
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
